EMEA-000358-PIP02-09

  • Email
  • Help

Overview

Product details for Advate
Invented nameAdvate
Active substance

Octocog alfa

Decision numberP/65/2010
PIP numberEMEA-000358-PIP02-09
Pharmaceutical form(s)Powder and solvent for solution for injection
Condition(s)/indication(s)

Haemophilia A (congenital Factor VIII deficiency)

Route(s) of administrationIntravenous use
PIP applicant

Applicant: Baxter AG
E-mail: juliana_brankova@baxter.com
Country: Austria
Phone: +43 1201002548
Fax: + 43 120100727

Decision typeW: decision granting a waiver in all age groups for the listed condition(s)

Decision

Related information